胰腺病学杂志(英文)(Journal of Pancreatology)

胰腺病学杂志(英文)(Journal of Pancreatology) 知网目次万方目次维普目次

  • 科核
基本信息
  • 主管单位:

    中国科学技术协会

  • 主办单位:

    中华医学会

  • 国际刊号:

    2096-5664;EISSN 2577-3577

  • 国内刊号:

    10-1560/R

  • 学科分类:

    内科学

  • 字数:

    6000-30000

  • 有无基金:

     

  • 周期:

    CN外文-季刊

  • 特殊属性:

    外文期刊

联系信息
  • 电话:

    010-69156016(官网电话)

  • 邮箱:

    jp@cmaph.org(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

    知网目次,万方目次,维普目次

  • 级别:

    科核

期刊简介

《胰腺病学杂志(英文)(Journal of Pancreatology)》期刊已被查看:

更新频次

单位占比

一作占比

投稿指南

1、投稿方式:在线投稿。

2、官网网址:http://jp.yiigle.com/

https://journals.lww.com/jpancreatology/pages/default.aspx

https://mednexus.org/journal/jp

3、投稿系统:

https://www.editorialmanager.com/jpancreatology

4、中华医学期刊网:

https://www.medjournals.cn/journalContribute/getJournalInfo.do?journalId=194

5、官网邮箱:jp@cmaph.org

(更多编辑邮箱请查看期刊官网信息)

6、出刊日期:季刊,逢季末月出版。

2023年9月11星期一

《胰腺病学杂志(英文)》投稿须知

【官网信息】

Instructions for Authors

AIMS AND SCOPE

The Journal of Pancreatology is a new, international peer-reviewed journal officially approved by the China Association for Science and Technology. This English-language publication will focus on diseases related to the pancreas as well as multi-disciplinary clinical approaches, including general surgery, gastroenterology, endocrinology, oncology, pathology, nuclear medicine, and radiology. Imaging modalities such as ultrasonography and pancreatic-related basic and clinical research will also be included. With strong support from the Peking Union Medical College Hospital, the Chinese Medical Association and the China Association for Science and Technology, the journal is poised to become a successful communications platform with high quality articles and broad scholarly impact. The journal was launched in December 2018 and will subsequently be published on a quarterly basis.

JOURNAL’S EDITORIAL POLICIES

The Editorial Process          

All manuscripts must be submitted online at: http://www.editorialmanager.com/jpancreatology; All manuscripts must be submitted along with Copyright Transfer Agreement.

For first-time users, please click the Register button at http://www.editorialmanager.com/jpancreatology. Upon successful registration, you will be sent an email providing your username and password. Save this information for future reference. Note: If you have received an email from us with an assigned username and password, or if you are a repeat user, you do not have to re-register.

All manuscripts that are received will be reviewed for possible publication with the understanding that they being submitted to Journal of Pancreatology alone at that point in time and have not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The Editorial team will subject all manuscripts submitted for consideration of publication in Journal of Pancreatology to plagiarism-detection software.

The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. The corresponding author’s responsibilities include:

Correspond with the editorial team on the editorial and review process to ensure manuscripts progress smoothly through the process. This involves providing reviewers with all the information they need, to guarantee authors to revise the manuscript per reviewers’ comments that improve the quality of their manuscript.

Compiling issues, making sure they are delivered on time and to the highest standard.

Editing, proof-reading, and reformatting manuscripts to ensure they are finished to a high quality and conform to the journal style.

Providing assistance with submissions and handling queries and problems.

For publishing and ethical standards, we follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals (http://www.icmje.org/recommendations/) issued by the International Committee of Medical Journal Editors (ICMJE) and the Cope of Conduct and Best Practice Guidelines for Journal Editors (http://publicationethics.org/files/Code_of_conduct_for_journal_editors.pdf) issued by the Committee on Publication Ethics (COPE).

Peer Review Process

Journal of Pancreatology operates a single-blind external peer review process, wherein the names of the reviewers are hidden from the author. Brief introduction on peer review process of the journal:

On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the readers of the journal are also liable to be rejected at this stage.

Manuscripts that are found suitable for potential publication of the journal are sent to a minimum of two independent expert reviewers to assess the scientific quality of the manuscript. Authors submitting manuscripts to Journal of Pancreatology may propose suitable reviewers or oppose reviewers who may have competing interests. The proposed reviewers should not be affiliated with the same institutes as the contributor(s). However, the selection of these reviewers is at the sole discretion of the editor, who selects reviewers to reflect relevant expertise, diversity, and geographical backgrounds.

Peer reviewers have access to the submitted manuscript and any appendices included by the authors. If the paper is a randomized controlled trial, peer reviewers will also have access to the trial protocol. Peer review assists editors in their decision on whether to publish an article and helps authors revise and improve their manuscripts. Peer reviewers make suggestions for improvements, critique the analysis, point out relevant published work which is not yet cited, and provide recommendations to the authors and the editors. At the Journal of Pancreatology, reviewer comments are sent to the authors anonymously. Details of peer review including dates and peer review comments are not shared publicly. Reviewed articles are treated confidentially prior to their publication.

Based on the comments from the reviewers, the handling editor takes an acceptance decision on the manuscript and convey the comments and suggestions (acceptance/ rejection/ amendments in manuscript) to the corresponding author, who is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated until reviewers and editors are satisfied with the manuscript. Manuscripts are accepted on the basis of quality, originality, significance, novelty and importance for the field.

Manuscripts received from Editorial Board Members will be screened by the Editor-in-Chief and sent to external peer reviewers. The Editorial Board Members, who are the contributing authors, will be excluded from publication decisions. Manuscripts received from Editor-in-Chief will be handled by Editorial Board Member of the journal and will be sent to external peer reviewers. The contributing Editor-in-Chief will be excluded from decision-making of his manuscript.

Editors are not involved in decisions about papers which they have written themselves or have been written by family members or colleagues or whoever relate to products or services in which the editor has an interest. Any such submission is subject to the journal’s standard procedures, with peer review handled independently of the relevant editor and their research groups.

……

更多详情:

https://edmgr.ovid.com/jpancreatology/accounts/ifauth.htm

中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。